Mary Ann Gray Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Mary Ann Gray is Director of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 12,356 shares of SRPT, which is worth approximately $1.5 Million. The most recent transaction as insider was on Mar 07, 2022, when has been sold 2,953 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4K
0% 3M change
0% 12M change
Total Value Held $1.5 Million

MARY ANN GRAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2022
BUY
Grant, award, or other acquisition
-
2,953 Added 19.29%
12,356 Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
-
967 Added 9.32%
9,403 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
2,726 Added 24.42%
8,436 Common Stock
Dec 10 2020
BUY
Exercise of conversion of derivative security
-
967 Added 14.48%
5,710 Common Stock

Also insider at

KROS
Keros Therapeutics, Inc. Healthcare
RAPT
RAPT Therapeutics, Inc. Healthcare
PALI
PALISADE BIO, INC. Healthcare
Director
BCAB
BioAtla, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
Director
MAG

Mary Ann Gray

Director
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT